XML 20 R5.htm IDEA: XBRL DOCUMENT v3.21.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Cumulative adjustment from adoption of recent accounting pronouncements
Common Stock
Additional Paid-in Capital
Retained Earnings
Retained Earnings
Cumulative adjustment from adoption of recent accounting pronouncements
Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Mar. 31, 2018     30,447,000        
Beginning balance at Mar. 31, 2018 $ 940,779 $ 468 $ 304 $ 167,587 $ 785,871 $ 468 $ (12,983)
Increase (Decrease) in Stockholders' Equity              
Stock-based compensation expense (in shares)     10,000        
Stock-based compensation expense 14,773     14,773      
Shares issued upon vesting (in shares)     85,000        
Shares issued upon vesting 1,025   $ 1 1,024      
Shares withheld for taxes $ (5,157)     (5,157)      
Repurchases of common stock (in shares) (1,400,699)   (1,401,000)        
Repurchases of common stock $ (161,395)   $ (14)   (161,381)    
Net income 264,308       264,308    
Total other comprehensive income (loss) (9,671)           (9,671)
Ending balance (in shares) at Mar. 31, 2019     29,141,000        
Ending balance at Mar. 31, 2019 1,045,130 $ (1,068) $ 291 178,227 889,266 $ (1,068) (22,654)
Increase (Decrease) in Stockholders' Equity              
Stock-based compensation expense (in shares)     10,000        
Stock-based compensation expense 14,471     14,471      
Shares issued upon vesting (in shares)     86,000        
Shares issued upon vesting 1,288   $ 1 1,287      
Exercise of stock options (in shares)     58,000        
Exercise of stock options 3,615   $ 1 3,614      
Shares withheld for taxes $ (6,148)     (6,148)      
Repurchases of common stock (in shares) (1,296,201)   (1,296,000)        
Repurchases of common stock $ (190,405)   $ (13)   (190,392)    
Net income 276,142       276,142    
Total other comprehensive income (loss) (2,905)           (2,905)
Ending balance (in shares) at Mar. 31, 2020     27,999,000        
Ending balance at Mar. 31, 2020 1,140,120   $ 280 191,451 973,948   (25,559)
Increase (Decrease) in Stockholders' Equity              
Stock-based compensation expense (in shares)     4,000        
Stock-based compensation expense 22,695     22,695      
Shares issued upon vesting (in shares)     107,000        
Shares issued upon vesting 1,502   $ 1 1,501      
Exercise of stock options (in shares)     107,000        
Exercise of stock options 6,775   $ 1 6,774      
Shares withheld for taxes $ (19,111)     (19,111)      
Repurchases of common stock (in shares) (307,080)   (307,000)        
Repurchases of common stock $ (99,147)   $ (3)   (99,144)    
Net income 382,575       382,575    
Total other comprehensive income (loss) 8,816           8,816
Ending balance (in shares) at Mar. 31, 2021     27,910,000        
Ending balance at Mar. 31, 2021 $ 1,444,225   $ 279 $ 203,310 $ 1,257,379   $ (16,743)